Following the completion of this course, learners should be able to:
- Understand the mechanism by which fentanyl is such a high-risk substance in pregnancy, the concerning use trends, and the available treatment options for decreasing maternal and neonatal morbidity and mortality.
- All participants will be able to answer >80% of the post-presentation assessment questions on fentanyl.
- Webinar attendees will have knowledge on an arsenal of treatment options, some of which are new and exciting, to help mitigate the effects of fentanyl use and overdose.
- Participants will understand the management of patients with history of fentanyl use in the intrapartum and postpartum period and how to apply simple, yet effective pain-management strategies.
- Attendees will be able to promptly implement strategies in their patient care to help minimize the development of neonatal opioid withdrawal syndrome (NOWS) and a potential novel syndrome related to fentanyl use during pregnancy.
- Participants will be equipped with the tools for properly addressing patients with fentanyl (and other substances) use in a way that minimizes stigma and provides patients with the comfort they need to seek care.
- Attendees will understand the importance of providing equitable care in a time where fentanyl use is on a dangerous rise by being familiar with the barriers to access to medications for opioid use disorder (MOUD).
Dr. Ljuba Mirsky, MD is a Maternal-Fetal-Medicine Fellow at the University of Kentucky (UK). She attended UK for her undergraduate studies and medical school, then completed her Obstetrics and Gynecology residency at the University of Tennessee Medical Center in Knoxville, TN. She has always been interested in substance use in pregnancy and completed research on Neonatal Opioid Withdrawal Syndrome (NOWS) in medical school and on a novel neonatal syndrome related to fentanyl exposure in fellowship. She currently works at the Pathways clinic when on rotation and is passionate about providing equitable care to this underserved population.
Cradle Cincinnati is a collective approach to ending infant mortality. They are a network of community members and organizations working across sectors to measurably improve Cincinnati's infant mortality rate, they bring together services and systems to help moms and, in turn, save babies' lives.
The Cradle Cincinnati Learning Collaborative (CCLC), launched in 2015, is a network of more than 200 healthcare professionals representing hospitals, community health centers, home health agencies, and social support organizations. These representatives are committed to transforming prenatal care for women and their families. At the heart of our work, we believe in providing equitable care that centers on women’s voices and experiences. Using data-sharing and an “all teach, all learn” model, the CCLC serves as an opportunity to activate change within the prenatal care space. We aim to lower infant mortality by focusing on activities and interventions related to the following focus areas: reducing extreme preterm birth, eliminating sleep-related infant death, preventing birth defects, and reducing the racial disparity in birth outcomes.
Presented by
Senior Data Management Specialist, D. Walker MPH, CHES
Senior Program Manager, L. Everett MPH
Learn more about Cradle Cincinnati
|
J. Murphy, MPH Kentucky Department for Public Health Division of Epidemiology and Health Planning Viral Hepatitis Program |
K. Gardner,
Kentucky Department for Public Health
Division of Epidemiology and Health Planning
Viral Hepatitis Program Coordinator
A new offering by Dr. Jessica Young, the Medical Director of the Firefly program, Acudetox is a treatment method that involves placing acupuncture needles gently in the ear at specific points. The intervention can provide symptom relief, relax the nervous system, calm emotions, and support patients in their recovery.
Background : Vanderbilt has been caring for women with substance use disorder and their children since 2011. In 2020, the program received funds from the Centers for Medicare & Medicaid Services (CMS) through the Maternal Opioid Misuse (MOM) model, in partnership with TennCare. This influx of support lead to the official launch of Firefly in 2021, an expanded, multi-disciplinary outpatient clinical program spanning OB/GYN, Pediatrics, & Psychiatry.
